Search Results

Cyclosporine

• Source: Funk & Wagnalls New World Encyclopedia. 2018, 1p.

Record details

Efficacy and safety of weekend cyclosporine treatment as maintenance therapy for preventing frequent disease exacerbations in moderate to severe chronic plaque psoriasis patients - A retrospective cohort study.

• Authors : Dogra S; Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.; Kumar S

Subjects: Psoriasis*/Psoriasis*/Psoriasis*/drug therapy ; Cyclosporine*/Cyclosporine*/Cyclosporine*/administration & dosage ; Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use

• Source: Indian journal of dermatology, venereology and leprology [Indian J Dermatol Venereol Leprol] 2024 Nov-Dec; Vol. 90 (6), pp. 707-712.Publisher: Scientific Scholar on behalf of Indian Association of Dermatologists, Venereologists & Leprologists Country of Publication: United States NLM ID: 7701852

Record details

Efficacy of tacrolimus versus cyclosporine after lung transplantation: an updated systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials.

• Authors : Suilik HA; Faculty of Medicine, Hashemite University, Zarqa, Jordan.; Al-Shammari AS

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Cyclosporine*/Cyclosporine*/Cyclosporine*/adverse effects ; Graft Rejection*/Graft Rejection*/Graft Rejection*/prevention & control

• Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Dec; Vol. 80 (12), pp. 1923-1935. Date of Electronic Publication: 2024 Sep 11.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

Chenodeoxycholic acid alleviated the cyclosporine-induced nephrotoxicity by decreasing oxidative stress and suppressing renin-angiotensin system through AT2R and ACE2 mRNA upregulation in rats.

• Authors : Bingül İ; Department of Medical Biochemistry, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. .; Kalayci R

Subjects: Chenodeoxycholic Acid*/Chenodeoxycholic Acid*/Chenodeoxycholic Acid*/pharmacology ; Renin-Angiotensin System*/Renin-Angiotensin System*/Renin-Angiotensin System*/drug effects ; Oxidative Stress*/Oxidative Stress*/Oxidative Stress*/drug effects

• Source: Journal of molecular histology [J Mol Histol] 2024 Dec 04; Vol. 56 (1), pp. 23. Date of Electronic Publication: 2024 Dec 04.Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 101193653 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Cyclosporine plus avatrombopag versus cyclosporine monotherapy for first-line treatment of elderly patients with transfusion-dependent non-severe aplastic anemia: a single center retrospective study.

• Authors : Zhang Z; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.; Hu Q

Subjects: Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/drug therapy ; Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/therapy ; Cyclosporine*/Cyclosporine*/Cyclosporine*/administration & dosage

• Source: Annals of medicine [Ann Med] 2024 Dec; Vol. 56 (1), pp. 2424451. Date of Electronic Publication: 2024 Nov 12.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Development and validation of a rapid HPLC-MS/MS method for simultaneous determination of cyclosporine A and tacrolimus in whole blood for routine therapeutic drug monitoring in organ transplantation.

• Authors : Han FF; Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.; Liu HC

Subjects: Tacrolimus*/Tacrolimus*/Tacrolimus*/blood ; Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/methods ; Cyclosporine*/Cyclosporine*/Cyclosporine*/blood

• Source: Rapid communications in mass spectrometry : RCM [Rapid Commun Mass Spectrom] 2025 Jan 30; Vol. 39 (2), pp. e9932.Publisher: John Wiley And Sons Ltd Country of Publication: England NLM ID: 8802365 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Population pharmacokinetics of cyclosporine A in hematopoietic stem cell transplant recipients: A systematic review.

• Authors : Yang Y; Department of Pharmacy, Shanghai Changhai Hospital, the First Affiliated Hospital of Navy Medical University, Shanghai, 200433, China.; Zhu Y

Subjects: Hematopoietic Stem Cell Transplantation* ; Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacokinetics ; Cyclosporine*/Cyclosporine*/Cyclosporine*/administration & dosage

• Source: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2025 Jan 01; Vol. 204, pp. 106882. Date of Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Improvement in signs and symptoms of severe dry eye disease after dual therapy with high-potency steroids and 0.05% cyclosporine.

• Authors : Lee CY; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Nobel Eye Institute, Taipei, Taiwan.

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/administration & dosage ; Cyclosporine*/Cyclosporine*/Cyclosporine*/adverse effects ; Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use

• Source: Annals of medicine [Ann Med] 2024 Dec; Vol. 56 (1), pp. 2391019. Date of Electronic Publication: 2024 Aug 19.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Positive response of a hemodialysis patient with pure red cell aplasia on recombinant human erythropoietin therapy to cyclosporine and Roxadustat.

• Authors : Ma X; Department of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; The First Clinical Medical College of Jinan University, Guangzhou, Guangdong, China.

Subjects: Red-Cell Aplasia, Pure*/Red-Cell Aplasia, Pure*/Red-Cell Aplasia, Pure*/drug therapy ; Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Cyclosporine*/Cyclosporine*/Cyclosporine*/administration & dosage

• Source: CEN case reports [CEN Case Rep] 2024 Dec; Vol. 13 (6), pp. 445-449. Date of Electronic Publication: 2024 Mar 25.Publisher: Springer Japan Country of Publication: Japan NLM ID: 101636244 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Comparison of therapeutic effects of 0.05% Cyclosporine A versus 0.1% Fluorometholone in Chinese patients with mild dry eye unresponsive to artificial tears: a randomized control study.

• Authors : Gao H; Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, 300384, China.; Department of Ophthalmology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Orbital Disease, Tianjin, 300211, China.

Subjects: Dry Eye Syndromes*/Dry Eye Syndromes*/Dry Eye Syndromes*/drug therapy ; Cyclosporine*/Cyclosporine*/Cyclosporine*/administration & dosage ; Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use

• Source: BMC ophthalmology [BMC Ophthalmol] 2024 Nov 27; Vol. 24 (1), pp. 513. Date of Electronic Publication: 2024 Nov 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415

Record details